Dexilant
NDC Package 50090-4374-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dexilant is dexlansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4374 and is authorized under FDA application NDA022287.

Identification & Billing

NDC Package Code
50090-4374-0
Package Description
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
50090437400
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA

Clinical Specifications

Proprietary Name
Dexilant
Dosage Form
-
Usage Information
Dexlansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Dexlansoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
NDA022287
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-12-2010
End Marketing Date
04-30-2022
Listing Expiration
04-30-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-4374-0 identifies a specific commercial package of 90 capsule, delayed release in 1 bottle of Dexilant, labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on April 12, 2010. The current certification is valid through April 30, 2022.

What are the primary indications for this medication?

Dexlansoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Dexlansoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090437400. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-4374-0
11-Digit CMS (5-4-2)
50090-4374-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.